In the matter of Recce Pharmaceuticals Ltd

Recce Pharmaceuticals Ltd applied to the Federal Court for an extension of time to issue cleansing notices under section 708A of the Corporations Act 2001 (Cth) in relation to securities issued without such notices. The company sought to correct an oversight where the cleansing notices were not issued within the statutory timeframe due to an honest and inadvertent error. The court was required to determine whether the failure to issue the notices was indeed an honest and inadvertent error, and if so, whether it was in the interests of justice to grant the extension.

The court considered the statutory provisions of section 708A and noted that the primary purpose of the requirement for a cleansing notice is to protect investors and ensure transparency in securities transactions. The court held that the failure to issue the notice was indeed an honest and inadvertent error. The company had acted promptly upon discovering the oversight and demonstrated a commitment to rectifying the situation. The court also took into account the lack of prejudice to the investors and the company's efforts to comply with its statutory obligations.

The court granted the application for an extension of time to issue the cleansing notices and made additional orders under section 1322 of the Corporations Act 2001 (Cth) to ensure that Recce Pharmaceuticals Ltd complied with its obligations going forward. The court ordered that the company issue the cleansing notices within a specified period and take steps to ensure that such errors did not occur in the future. The court's decision balanced the need to protect investors with the recognition of the company's honest mistake and its efforts to rectify the situation.